This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Ampio Pharmaceuticals Inc (AMPE)

AMEX: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 26.31M 17.68M 11.36M 671.28K
Receivables 0.00 0.00 0.00 5.71K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 164.89K 43.12K 60.53K
Total Current Assets 26.44M 17.85M 11.41M 737.52K
Property, Plant & Equipment, Gross 1.40M 84.70K 84.70K 0.00
Accumulated Depreciation & Depletion 97.58K 25.42K 8.48K 0.00
Property, Plant & Equipment, Net 1.30M 59.29K 76.23K 0.00
Intangibles 8.23M 420.47K 465.92K 0.00
Other Non-Current Assets 43.86K 7.52M 7.54M 0.00
Total Non-Current Assets 9.58M 8.00M 8.08M 0.00
Liabilities & Shareholder Equity
Total Assets 36.02M 25.85M 19.48M 737.52K
Accounts Payable 1.90M 1.20M 630.62K 1.67M
Short Term Debt 0.00 0.00 0.00 2.13M
Other Current Liabilities 0.00 384.77K 610.91K 398.67K
Total Current Liabilities 2.47M 1.64M 1.29M 4.75M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 331.25K 381.25K 431.25K 0.00
Minority Interest -519.87K 0.00 0.00 0.00
Total Non-Current Liabilities 468.96K 381.25K 431.25K 0.00
Total Liabilities 2.94M 2.02M 1.72M 4.75M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 33.08M 23.83M 17.76M -4.01M
Common Par 4.21K 3.70K 3.11K 1.71K
Additional Paid In Capital 96.94M 63.69M 46.06M 5.96M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -63.78M -39.77M -28.18M -9.82M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -90.64K -90.64K -127.52K -153.46K
Total Capitalization 33.08M 23.83M 17.76M -4.01M
Total Equity 33.08M 23.83M 17.76M -4.01M
Total Liabilities & Stock Equity 36.02M 25.85M 19.48M 737.52K
Total Common Shares Outstanding 42.07M 37.01M 31.08M 17.11M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 38.29M 33.98M 26.01M 16.29M
Diluted Weighted Shares Outstanding 38.29M 33.98M 26.01M 16.29M
Number of Employees 16 13 12 11
Number of Part-Time Employees 0 0 0 0

AMPE Ampio Pharmaceuticals Inc

Analysts Ratings for AMPE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

AMPE Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs